TLR7 and breast cancer: Also, the immunosuppressive activity and differentiation of MDSCs isolated from breast cancer patients were examined before and after targeting the STAT3 transcription factor using siRNA in MDSCs along with simultaneous activation of the TLR7/TLR8 signaling using a specific agonist.